1 withdrawn. 1 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 1 | Withdrawn 1 |
Follow Todd Doyle: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Vortioxetine Monotherapy for Major Depressive Disorder in Type 2 Diabetes Vortioxetine - Type2 Diabetes, Major Depressive Disorder | Phase 4 | Withdrawn | Todd Doyle | 2019-07-01 | 2022-11-29 |
Depressive Disorder, Major (1) · Diabetes Mellitus, Type 2 (1)
Vortioxetine (1)
United States (1)